<DOC>
	<DOCNO>NCT01073709</DOCNO>
	<brief_summary>The study conduct open label , balance , randomize , two-treatment , two-period , two-sequence , single-dose , crossover , bioavailability study compare acetaminophen extend release gelcaps 650 mg OHM Laboratories Inc. TylenolÂ® Arthritis Pain caplets 650 mg McNeil Consumer &amp; Specialty Pharmaceuticals , healthy , adult , human , male subject fast condition .</brief_summary>
	<brief_title>A Relative Bioavailability Study Acetaminophen 650 mg Extended Release Gelcaps Under Fasting Condition</brief_title>
	<detailed_description>Following overnight fast least 10 hour , subject administer single oral dose acetaminophen 650 mg extend release tablet administer 240 mL drinking water period study supervision train study personnel . Both test ( T ) reference ( R ) product administer study subject , one period ( except subject 40 ) . During course study , safety parameter assess vital sign , clinical examination , medical history clinical laboratory safety test ( hematology , biochemical , serology parameter , urine analysis urine drug screen ) measure base line . Laboratory parameter haematology biochemistry ( except glucose cholesterol ) repeat end study .</detailed_description>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Were age range 1845 year . Were neither overweight underweight height per Life Insurance Corporation India height/weight chart nonmedical case . Had voluntarily give write informed consent participate study . Were normal health determine medical history physical examination subject perform within 21 day prior commencement study . There deviation regard . History hypersensitivity acetaminophen relate drug . History skin rash , thrombocytopenia , urticaria angioedema . History peptic ulcer disease . Recent history nausea vomit Any evidence organ dysfunction clinically significant deviation normal , physical clinical determination . Presence disease marker HIV 1 2 , Hepatitis B C viruses syphilis infection . Presence value significantly different normal reference range and/or judge clinically significant haemoglobin , total white blood cell count , differential WBC count platelet count . Positive urinary screen test drug abuse ( opiates cannabinoids ) Presence value , significantly different normal reference range and/or judge clinically significant serum creatinine , blood urea nitrogen , serum aspartate aminotransferase ( AST ) , serum alanine aminotransferase ( ALT ) , serum alkaline phosphatase , serum bilirubin , plasma glucose serum cholesterol . Clinically abnormal chemical microscopic examination urine define presence RBC , WBC ( &gt; 4/HPF ) , epithelial cell ( &gt; 4/HPF ) , glucose ( positive ) protein ( positive ) . Clinically abnormal ECG Chest Xray . History serious gastrointestinal , hepatic , renal , cardiovascular , pulmonary , neurological haematological disease , diabetes glaucoma . History psychiatric illness , might impair ability provide write informed consent . Regular smoker smoke 10 cigarette daily difficulty abstain smoke duration study period . History drug dependence excessive alcohol intake habitual basis 2 unit alcoholic beverage per day ( 1 unit equivalent half pint beer 1 glass wine 1 measure spirit ) difficulty abstain duration study period . Had use enzyme modify drug within 30 day prior Day 1 study . Participated clinical trial within 12 week precede Day 1 study . Subjects , completion study , would donate and/or lose 350 mL blood past 3 month . There deviation regard .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Acetaminophen fasting study</keyword>
</DOC>